Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

T-Bird Pharma Inc. V.TPI



TSXV:TPI - Post by User

Post by HTCapitalCorpon Mar 31, 2015 11:06am
193 Views
Post# 23581337

T-Bird Pharma Inc. Announces Final Municipal Rezoning Approv

T-Bird Pharma Inc. Announces Final Municipal Rezoning ApprovVICTORIA, BC, March 31, 2015 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or the "Company"), a pharmaceutical company focused on developing premium quality medical marijuana products and a licensed producer ("LP") to cultivate marijuana under the Marihuana for Medical Purposes Regulations (Canada) ("MMPR"), is pleased to announce that it has received notice from The Corporation of the District of Saanich confirming the final rezoning approval of the Company's premises which now allows for commercial distribution of medical marijuana under the MMPR. Saanich Council, at their meeting on March 23, 2015, gave final reading and adoption to "ZONING BYLAW, 2003, AMENDMENT BYLAW, 2014, NO.9308" and "ZONING BYLAW, 2003, AMENDMENT BYLAW, 2015, NO. 9309", the effect of which is to add a new definition for medical marihuana production and distribution, and to amend zone M-3 (industrial park) to permit that use on Strata Lot 1, Section 100, Lake District, Plan VIS4905 (Unit 101-4226 Commerce Circle). "We are excited to have the rezoning of our premises finalized and thankful for the support of Saanich Council, said Dr.Bin Huang, CEO of T-Bird. "This is a significant step as we work towards commercialization and securing a sales license under the MMPR." About T-Bird and Thunderbird T-Bird Pharma Inc. is the parent company of Thunderbird Biomedical Inc., a wholly owned private subsidiary formed in January, 2013. The principal activities of Thunderbird are the production of marijuana from its Victoria, British Columbia production facility, as regulated by the Marihuana for Medical Purposes Regulations (Canada). Thunderbird obtained a medical marijuana license to undertake the production of medical marijuana in February 2014, being the fifth company in Canada to obtain such a license. Thunderbird was acquired by T-Bird in September, 2013. ON BEHALF OF THE BOARD "David J. Raffa" Chairman Read more at https://www.stockhouse.com/news/press-releases/2015/03/31/t-bird-pharma-inc-announces-final-municipal-rezoning-approval#HfdlAbVWBrUESQtr.99
<< Previous
Bullboard Posts
Next >>